| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 79246 |
Mal-amido-PEG2-Val-Cit-PAB-OH，马来酰亚胺-酰胺-二聚乙二醇-缬氨酸-瓜氨酸-PAB-羟基 |
86 |
WYQ |
2024-12-18 |
| 79247 |
CAS号：1949793-41-2 ，Mal-amido-PEG4-Val-Cit-PAB-OH |
97 |
WYQ |
2024-12-18 |
| 79248 |
DOTA-伊班膦酸 DOTA-IBA |
114 |
h |
2024-12-18 |
| 79249 |
FA-DOTA-PEG-PLGA 叶酸-DOTA-聚乙二醇-聚乳酸-羟基乙酸共聚物 |
103 |
h |
2024-12-18 |
| 79250 |
DOTA-泛素29-41 |
97 |
h |
2024-12-18 |
| 79251 |
cas:1226403-39-9，N-(2-(3,4-Difluorophenoxy)ethyl)-4-formylbenzamide |
104 |
kx |
2024-12-18 |
| 79252 |
Cu-64 DOTA-曲妥珠单抗 Cu-64-Herceptin |
164 |
h |
2024-12-18 |
| 79253 |
CAS号：2112738-13-1 ，Mal-amido-PEG2-Val-Cit-PAB-PNP |
103 |
WYQ |
2024-12-18 |
| 79254 |
CAS号：2055041-40-0 ， Azido-PEG1-Val-Cit-PAB-OH |
105 |
WYQ |
2024-12-18 |
| 79255 |
cas:1226006-55-8，N-(2-(3-Ethoxyphenoxy)ethyl)-4-formylbenzamide， ADC试剂 |
84 |
kx |
2024-12-18 |
| 79256 |
DOTA-LTVSPWY 双功能螯合剂DOTA偶联肽LTVSPWY |
110 |
h |
2024-12-18 |
| 79257 |
CAS号：2055024-65-0 ，Azido-PEG3-Val-Cit-PAB-OH |
107 |
WYQ |
2024-12-18 |
| 79258 |
DOTA-CCK-66 大环DOTA偶联CCK2R靶向化合物CCK-66 |
280 |
h |
2024-12-18 |
| 79259 |
cas:1228153-04-5，4-Formyl-N-(2-(naphthalen-2-yloxy)ethyl)benzamide |
125 |
kx |
2024-12-18 |
| 79260 |
抗DOTA IgG-scFv BsAb anti-DOTA IgG-scFv BsAb |
164 |
h |
2024-12-18 |
| 79261 |
cas:1226217-30-6，4-Formyl-N-(2-(4-isopropylphenoxy)ethyl)benzamide |
129 |
kx |
2024-12-18 |
| 79262 |
DOTA-rL-A9肽 DOTA偶联核定位序列(NLS)-移植的her 2-受体亲和肽 |
133 |
h |
2024-12-18 |
| 79263 |
cas:796073-59-1，2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
86 |
kx |
2024-12-18 |
| 79264 |
DOTA-E[c(RGDFK)]2 双功能螯合剂偶联的RGD多肽E[c(RGDfK)]2 |
92 |
h |
2024-12-18 |
| 79265 |
DBCO-C4-Val-Cit-PABC-PNP，分子式：C46H49N7O10 |
104 |
WYQ |
2024-12-18 |
| 79266 |
DBCO-(PEG)3-VC-PAB-MMAE，CAS号：57103-68-1 |
75 |
WYQ |
2024-12-18 |
| 79267 |
cas:1134280-65-1，2,5-Dioxopyrrolidin-1-yl 3-((2,4-difluorobenzyl)oxy)propanoate |
100 |
kx |
2024-12-18 |
| 79268 |
DBCO-PEG3-acetic-Val-Cit-PAB（二苯并环辛炔） |
108 |
WYQ |
2024-12-18 |
| 79269 |
cas:1824718-79-7，SPDH， ADC试剂 |
103 |
kx |
2024-12-18 |
| 79270 |
cas:1232769-29-7，2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate |
107 |
kx |
2024-12-18 |
| 79271 |
Amino-PEG2-VG-N-Bis(PEG1-azide)，氨基-二聚乙二醇-VG-N-双（一聚乙二醇-叠氮） |
152 |
WYQ |
2024-12-18 |
| 79272 |
Alkyne-Val-Cit-PAB-FAM，炔-VAL-CIT-PAB-FAM |
90 |
WYQ |
2024-12-18 |
| 79273 |
cas:1226218-43-4，4-Formyl-N-(2-(2,3,6-trimethylphenoxy)ethyl)benzamide |
94 |
kx |
2024-12-18 |
| 79274 |
双功能螫合剂DOTA偶联MAG3 DOTA-MAG3 |
130 |
h |
2024-12-18 |
| 79275 |
Alkyne-Val-Cit-PAB-PNP，炔-Val-Cit-PAB-PNP |
111 |
WYQ |
2024-12-18 |
| 79276 |
DOTA-MSH2 金属螯合剂DOTA偶联二聚体肽(MSH2) |
119 |
h |
2024-12-18 |
| 79277 |
cas:796073-64-8，(S)-2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
94 |
kx |
2024-12-18 |
| 79278 |
N,N-二乙基正辛硫基乙酰胺,(N,N-Diethyl-α-(OctlyThio)-Acetamide)简称DOTA |
92 |
h |
2024-12-18 |
| 79279 |
cas:437655-95-3，Fmoc-NH-PEG4-CH2COOH， 5,8,11,14-四氧杂-2-氮杂十六碳二酸 1-芴甲基酯 |
108 |
kx |
2024-12-18 |
| 79280 |
Val-Ala-PAB-OH |
126 |
zyl |
2024-12-18 |
| 79281 |
DOTA-Bz-Cys-RGD dimer 双功能螯合剂修饰Cys-RGD dimer |
104 |
h |
2024-12-18 |
| 79282 |
cas:874208-92-1，m-PEG7-NHS ester， ADC试剂 |
111 |
kx |
2024-12-18 |
| 79283 |
Boc-PEG4-Val-Ala-PAB-PNP |
104 |
zyl |
2024-12-18 |
| 79284 |
111 In-奥曲肽(Octreo Scan) |
438 |
h |
2024-12-18 |
| 79285 |
POSS-DOTA 大环配体DOTA偶联七异丁基-氨丙基六面体倍半硅氧烷POSS |
112 |
h |
2024-12-18 |
| 79286 |
cas:164332-88-1，N-Boc-PEG1-bromide， [2-(2-溴乙氧基)乙基]氨基甲酸叔丁酯 |
98 |
kx |
2024-12-18 |
| 79287 |
DOTA-Substance P DOTA-SP |
128 |
h |
2024-12-18 |
| 79288 |
Mal-amido-PEG8-val-gly-PAB-OH CAS:2353409-52-4 |
112 |
zyl |
2024-12-18 |
| 79289 |
FITC-Gly-Gly-Gly-CBT |
95 |
h |
2024-12-18 |
| 79290 |
FITC-Gly-Gly-Gly-CBT |
139 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询